Join the Beacon Asia Tour - Kicking Off May 19th! Learn More

Customer Spotlight

Amgen on Antibody Discovery and Cell Line Development

amgen-logo
CUSTOMER QUOTE
โ€œIn the long run, this technology will help us to solve complex problems that are too hard or expensive to solve with our current tools.โ€

โ€” Philip Tagari, Vice President of Therapeutic Discovery, Amgen

TRANSFORMATIVE TECHNOLOGY

As one of the early customers to have adopted the Beacon Platform, Mr. Tagari and his colleagues at Amgen have been able to continuously push the capabilities of the Beaconยฎ optofluidic system. Since adoption, Amgen has expanded their usage of the platform from antibody discovery to cell line development. Mr. Tagari describes the Beacon technology in Amgenโ€™s online feature โ€œWeโ€™ve actually put this technology into practice in our antibody discovery work, and it takes about four months off the normal timeline. Itโ€™s also our standard method for cell line development, and weโ€™re looking to extend our success in these areas to other applications. Itโ€™s starting to feel like a pretty transformative tool.โ€

Visual record of a clone through multiple days of culture in a NanoPenโ„ข chamber on an OptoSelectโ„ข chip.
Visual record of a clone through multiple days of culture in a NanoPenโ„ข chamber on an OptoSelectโ„ข chip.

As noted by Amgenโ€™s scientists, using previous methods of hybridoma fusion for antibody discovery starts out with 0.1% of B cells surviving the fusion, not to mention the weeks it takes to grow the millions of cells for screening.

With the Beacon system you can skip the entire hybridoma model, getting to your answers faster and with more relevant data. You can directly assay the B cells and connect antibody function to gene sequence at the single-cell level.

figure1-2048x482-1 (1)

Explore Customer Spotlights

Customer Spotlight
MYCENAX: Developing the Next-Gen Cell Line Development Platform with Bruker Cellular Analysis
Customer Spotlight
Medical College of Wisconsin on T Cell Characterization
Customer Spotlight
Genovac on Antibody Discovery
Customer Spotlight
Catalent Biologics on Cell Line Development
Customer Spotlight
Abveris on Antibody Discovery